Last reviewed · How we verify
NCT06897059
Effectiveness of Smartphone Application for Adherence Support (Vuka+)
NA trial testing Vuka+ application in Adherence, Medication in 330 participants. Completed in 8 November 2024.
1 March 2024
Quick facts
| Lead sponsor | Eastern Virginia Medical School |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 330 |
| Start date | 15 December 2022 |
| Primary completion | 1 March 2024 |
| Estimated completion | 8 November 2024 |
| Sites | 1 location across South Africa |
Drugs / interventions tested
- Vuka+ application
Conditions studied
- Adherence, Medication — all drugs for Adherence, Medication →
- Smartphone Application — all drugs for Smartphone Application →
Sponsor
Eastern Virginia Medical School
Who can join
Adults 15 to 24, female only, with Adherence, Medication or Smartphone Application. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a Type I Hybrid effectiveness-implementation trial to evaluate an HIV Pre-Exposure Prophylaxis (PrEP) medication adherence, persistence and social support app (Vuka+) for adolescent girls and young women (AGYW) in South Africa. This 6-month, 2-arm effectiveness and implementation trial (standard of care \[SOC\] vs. intervention app) will assess acceptability, feasibility and effectiveness. In addition, we will gather information on intervention delivery and barriers and facilitators for real-world delivery to inform future implementation and scale up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06897059
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adherence, Medication
Currently open trials in the same condition.
- NCT06759805 — Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study · NA · recruiting
- NCT05613010 — Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant · NA · recruiting
- NCT06056037 — Making ART Work Among Brazilian Youth · NA · recruiting
- NCT05619601 — Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction · active not recruiting
- NCT05374109 — SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth · NA · active not recruiting
Other Eastern Virginia Medical School trials
Trials by the same sponsor.
- NCT07224893 — Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management · Phase 4 · not yet recruiting
- NCT07119398 — Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM · Phase 4 · recruiting
- NCT06867861 — Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes · NA · recruiting
- NCT06274398 — Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study · Phase 1 · completed
- NCT06087913 — Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06897059 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eastern Virginia Medical School
- Last refreshed: 26 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06897059.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing